Redhill Biopharma Stock Forward View
| RDHL Stock | USD 1.00 0.01 1.01% |
Redhill Stock outlook is based on your current time horizon. Although Redhill Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Redhill Biopharma's systematic risk associated with finding meaningful patterns of Redhill Biopharma fundamentals over time.
As of now the relative strength index (rsi) of Redhill Biopharma's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Wall Street Target Price 19 K | Quarterly Revenue Growth 0.586 |
Using Redhill Biopharma hype-based prediction, you can estimate the value of Redhill Biopharma from the perspective of Redhill Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Redhill Biopharma on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.03. Redhill Biopharma after-hype prediction price | USD 1.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Redhill Biopharma to cross-verify your projections. Redhill Biopharma Additional Predictive Modules
Most predictive techniques to examine Redhill price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Redhill using various technical indicators. When you analyze Redhill charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Redhill Biopharma Cash Forecast
To forecast cash or other financial indicators, analysts must employ diverse statistical methods, techniques, and algorithms. This approach allows them to detect underlying patterns in the Redhill Biopharma's financial statements, predicting their influence on future market prices.
Cash | First Reported 2010-12-31 | Previous Quarter 2.9 M | Current Value 2.9 M | Quarterly Volatility 18.7 M |
Redhill Biopharma Naive Prediction Price Forecast For the 18th of February 2026
Given 90 days horizon, the Naive Prediction forecasted value of Redhill Biopharma on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.03.Please note that although there have been many attempts to predict Redhill Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Redhill Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Redhill Biopharma Stock Forecast Pattern
| Backtest Redhill Biopharma | Redhill Biopharma Price Prediction | Research Analysis |
Redhill Biopharma Forecasted Value
In the context of forecasting Redhill Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Redhill Biopharma's downside and upside margins for the forecasting period are 0.01 and 7.00, respectively. We have considered Redhill Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Redhill Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Redhill Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.6772 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0496 |
| MAPE | Mean absolute percentage error | 0.0431 |
| SAE | Sum of the absolute errors | 3.0255 |
Predictive Modules for Redhill Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Redhill Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Redhill Biopharma After-Hype Price Density Analysis
As far as predicting the price of Redhill Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Redhill Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Redhill Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Redhill Biopharma Estimiated After-Hype Price Volatility
In the context of predicting Redhill Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Redhill Biopharma's historical news coverage. Redhill Biopharma's after-hype downside and upside margins for the prediction period are 0.05 and 7.07, respectively. We have considered Redhill Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Redhill Biopharma is very steady at this time. Analysis and calculation of next after-hype price of Redhill Biopharma is based on 3 months time horizon.
Redhill Biopharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Redhill Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Redhill Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Redhill Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 6.06 | 0.01 | 0.01 | 12 Events / Month | 6 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.00 | 1.01 | 1.00 |
|
Redhill Biopharma Hype Timeline
Redhill Biopharma is at this time traded for 1.00. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.01. Redhill is forecasted to increase in value after the next headline, with the price projected to jump to 1.01 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 1.0%, whereas the daily expected return is at this time at 0.09%. The volatility of related hype on Redhill Biopharma is about 5474.25%, with the expected price after the next announcement by competition of 0.99. The company reported the previous year's revenue of 8.04 M. Net Loss for the year was (8.27 M) with profit before overhead, payroll, taxes, and interest of 6.16 M. Given the investment horizon of 90 days the next forecasted press release will be in about 12 days. Check out Historical Fundamental Analysis of Redhill Biopharma to cross-verify your projections.Redhill Biopharma Related Hype Analysis
Having access to credible news sources related to Redhill Biopharma's direct competition is more important than ever and may enhance your ability to predict Redhill Biopharma's future price movements. Getting to know how Redhill Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Redhill Biopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IMCC | Im Cannabis Corp | 0.05 | 8 per month | 0.00 | (0.03) | 12.57 | (10.92) | 53.15 | |
| BGMS | Bio Green Med | 0.02 | 4 per month | 0.00 | (0.05) | 12.80 | (8.79) | 42.74 | |
| CNSP | CNS Pharmaceuticals | (0.49) | 5 per month | 0.00 | (0.17) | 7.22 | (8.99) | 31.54 | |
| AKAN | Akanda Corp | 0.20 | 10 per month | 0.00 | (0.24) | 11.11 | (20.00) | 64.81 | |
| BNBX | Applied DNA Sciences | (0.11) | 6 per month | 0.00 | (0.21) | 11.06 | (13.40) | 52.07 | |
| MSPR | MSP Recovery | 0 | 7 per month | 0.00 | (0.03) | 46.34 | (22.50) | 139.00 | |
| FLGC | Flora Growth Corp | (0.30) | 5 per month | 0.00 | (0.02) | 9.42 | (12.32) | 30.99 | |
| GCTK | GlucoTrack | (0.18) | 4 per month | 0.00 | (0.22) | 8.36 | (10.40) | 56.93 | |
| JAGX | Jaguar Animal Health | (0.01) | 9 per month | 0.00 | (0.06) | 10.14 | (16.87) | 125.57 | |
| SXTP | 60 Degrees Pharmaceuticals | (0.29) | 8 per month | 7.94 | 0.03 | 10.44 | (14.26) | 166.26 |
Other Forecasting Options for Redhill Biopharma
For every potential investor in Redhill, whether a beginner or expert, Redhill Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Redhill Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Redhill. Basic forecasting techniques help filter out the noise by identifying Redhill Biopharma's price trends.Redhill Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Redhill Biopharma stock to make a market-neutral strategy. Peer analysis of Redhill Biopharma could also be used in its relative valuation, which is a method of valuing Redhill Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Redhill Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Redhill Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Redhill Biopharma shares will generate the highest return on investment. By undertsting and applying Redhill Biopharma stock market strength indicators, traders can identify Redhill Biopharma entry and exit signals to maximize returns.
Redhill Biopharma Risk Indicators
The analysis of Redhill Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Redhill Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting redhill stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.47 | |||
| Semi Deviation | 3.43 | |||
| Standard Deviation | 5.85 | |||
| Variance | 34.24 | |||
| Downside Variance | 14.62 | |||
| Semi Variance | 11.79 | |||
| Expected Short fall | (5.02) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Redhill Biopharma
The number of cover stories for Redhill Biopharma depends on current market conditions and Redhill Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Redhill Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Redhill Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Redhill Biopharma Short Properties
Redhill Biopharma's future price predictability will typically decrease when Redhill Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Redhill Biopharma often depends not only on the future outlook of the potential Redhill Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Redhill Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.5 M | |
| Cash And Short Term Investments | 4.6 M |
Check out Historical Fundamental Analysis of Redhill Biopharma to cross-verify your projections. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. Anticipated expansion of Redhill directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Redhill Biopharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Redhill Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Redhill Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Redhill Biopharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.